Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

RANDALL W BROWN

Allopathic & Osteopathic Physicians Pediatrics Pediatric Pulmonology

NPI
1043234313
CMS profile
137617
Location
ATLANTA, GA

General Payments · PY2018–2019

$259,945.36

  • Reported across 324 records
  • CMS publication 2026-01-23

Latest program year · PY2019

$25,885.75

25 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2019 · sorted by reported total

By paying entity

PY2019 · sorted by reported total

Paying entityAmountRecords
Acerta Pharma LLC $12,301.46 16
Teva Pharmaceuticals USA, Inc. $8,545.18 5
NOVARTIS PHARMACEUTICALS CORPORATION $5,039.11 4

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $234,059.61 299
PY2019 $25,885.75 25

Payment records · PY2019 (25)

Sorted by paying entity, then date · as published by CMS

Program year 2019 2018 Record-level detail is published for PY2019; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
AstraZeneca Pharmaceuticals LP $805.11 02/26/2019 Travel and Lodging Undisputed 01/23/2026 685220935 CMS
AstraZeneca Pharmaceuticals LP $97.40 02/26/2019 Food and Beverage Undisputed 01/23/2026 685228579 CMS
AstraZeneca Pharmaceuticals LP $101.38 02/26/2019 Travel and Lodging Undisputed 01/23/2026 685705963 CMS
AstraZeneca Pharmaceuticals LP $289.06 02/26/2019 Travel and Lodging Undisputed 01/23/2026 685794649 CMS
AstraZeneca Pharmaceuticals LP $17.50 02/26/2019 Food and Beverage Undisputed 01/23/2026 685887217 CMS
AstraZeneca Pharmaceuticals LP $2,700.00 03/13/2019 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 685443421 CMS
AstraZeneca Pharmaceuticals LP $11.16 04/24/2019 Food and Beverage Undisputed 01/23/2026 685127099 CMS
AstraZeneca Pharmaceuticals LP $388.30 04/24/2019 Travel and Lodging Undisputed 01/23/2026 685891305 CMS
AstraZeneca Pharmaceuticals LP $79.87 04/25/2019 Travel and Lodging Undisputed 01/23/2026 685109505 CMS
AstraZeneca Pharmaceuticals LP $221.00 04/25/2019 Travel and Lodging Undisputed 01/23/2026 685129643 CMS
AstraZeneca Pharmaceuticals LP $322.56 04/25/2019 Travel and Lodging Undisputed 01/23/2026 685211101 CMS
AstraZeneca Pharmaceuticals LP $18.12 04/25/2019 Food and Beverage Undisputed 01/23/2026 685778539 CMS
AstraZeneca Pharmaceuticals LP $2,700.00 05/05/2019 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 685126009 CMS
AstraZeneca Pharmaceuticals LP $3,100.00 05/05/2019 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 685172911 CMS
AstraZeneca Pharmaceuticals LP $1,150.00 05/05/2019 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 685648067 CMS
AstraZeneca Pharmaceuticals LP $300.00 05/27/2019 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 685892929 CMS
Novartis Pharmaceuticals Corporation $213.18 05/24/2019 Travel and Lodging Undisputed 01/23/2026 658812375 CMS
Novartis Pharmaceuticals Corporation $1,107.00 05/24/2019 Travel and Lodging Undisputed 01/23/2026 658812377 CMS
Novartis Pharmaceuticals Corporation $3,683.50 05/24/2019 Consulting Fee Undisputed 01/23/2026 658812383 CMS
Novartis Pharmaceuticals Corporation $35.43 05/24/2019 Food and Beverage Undisputed 01/23/2026 659107774 CMS
Teva Pharmaceuticals USA, Inc. $15.18 05/04/2019 Food and Beverage Undisputed 01/23/2026 697755911 CMS
Teva Pharmaceuticals USA, Inc. $450.00 06/19/2019 Consulting Fee Undisputed 01/23/2026 697861897 CMS
Teva Pharmaceuticals USA, Inc. $4,040.00 08/06/2019 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 697861895 CMS
Teva Pharmaceuticals USA, Inc. $2,020.00 08/16/2019 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 697861893 CMS
Teva Pharmaceuticals USA, Inc. $2,020.00 08/21/2019 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 697861891 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019
Source files
Dataset page · Bulk file · PY2018 , PY2019
Generated from
OP_DTL_GNRL_PGYR2019_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.